(Q73493513)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9215302%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9215302%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome1 (English)

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

polycystic ovary syndrome

12 September 2024

main subject

1 reference

1 reference

2

B. McCourt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9215302

12 September 2024

author name string

A. E. Taylor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9215302

12 September 2024

K. A. Martin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9215302

12 September 2024

E. J. Anderson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9215302

12 September 2024

J. M. Adams

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9215302

12 September 2024

D. Schoenfeld

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9215302

12 September 2024

J. E. Hall

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9215302

12 September 2024

language of work or name

English

0 references

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9215302%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

4 November 2019

published in

The Journal of Clinical Endocrinology and Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9215302%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9215302%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9215302%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

2248-2256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9215302%20AND%20SRC:MED&resulttype=core&format=json

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

4 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.

12 September 2024

2

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

12 September 2024

3

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Polycystic ovary syndrome: a changing perspective

12 September 2024

4

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

The polycystic ovary syndrome

12 September 2024

5

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome

12 September 2024

7

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea

12 September 2024

8

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Which hormone tests for the diagnosis of polycystic ovary syndrome?

12 September 2024

10

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Hormonal studies on women with polycystic ovaries diagnosed by ultrasound

12 September 2024

11

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation.

12 September 2024

12

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

12 September 2024

15

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.

12 September 2024

17

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome

12 September 2024

18

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.

12 September 2024

19

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.

12 September 2024

20

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease

12 September 2024

21

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women

12 September 2024

22

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Obesity, serum steroid levels, and pulsatile gonadotropin secretion in polycystic ovarian disease

12 September 2024

23

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Clinical findings and hormonal responses in patients with polycystic ovarian disease with normal versus elevated LH levels

12 September 2024

24

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Androgen and insulin response to an oral glucose challenge in hyperandrogenic women.

12 September 2024

25

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome

12 September 2024

27

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases

12 September 2024

28

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men

12 September 2024

29

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

12 September 2024

31

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Clinical assessment of body hair growth in women

12 September 2024

32

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years

12 September 2024

35

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Specific resistivity used to estimate fat-free mass from segmental body measures of bioelectric impedance

12 September 2024

36

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men

12 September 2024

39

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion

12 September 2024

40

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease

12 September 2024

43

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Vaginal progesterone administration before ovulation induction with exogenous gonadotropins in polycystic ovarian syndrome

12 September 2024

44

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Pulsatile gonadotropin output in menstrual dysfunction

12 September 2024

45

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease

12 September 2024

46

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.

12 September 2024

47

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Pituitary-Ovarian Relationships in Polycystic Ovary Syndrome

12 September 2024

48

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Detection of Functional Ovarian Hyperandrogenism in Women with Androgen Excess

12 September 2024

51

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

12 September 2024

52

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease

12 September 2024

53

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO

12 September 2024

54

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease

12 September 2024

55

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

12 September 2024

56

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

The effects of fasting on serum and urinary gonadotropins in obese postmenopausal women.

12 September 2024

59

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Studies on the metabolic clearance rate and production rate of human luteinizing hormone and on the initial half-time of its subunits in man

12 September 2024

60

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Metabolic clearance rates of luteinizing hormone in women during different phases of the menstrual cycle and while taking an oral contraceptive

12 September 2024

61

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

12 September 2024

62

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

12 September 2024

63

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

12 September 2024

64

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome

12 September 2024

65

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

Gonadotropin profiles in fed and fasted obese women

12 September 2024

66

1 reference

https://api.crossref.org/works/10.1210/JCEM.82.7.4105

12 September 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9215302%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference